🇺🇸 FDA
Patent

US 8383576

LKKTET and/or LKKTNT peptide compositions which are lyophilized or in a form capable of being lyophilized

granted A61KA61K38/08A61K38/2292

Quick answer

US patent 8383576 (LKKTET and/or LKKTNT peptide compositions which are lyophilized or in a form capable of being lyophilized) held by REGENERX BIOPHARMACEUTICALS, INC. expires Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERX BIOPHARMACEUTICALS, INC.
Grant date
Tue Feb 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K38/08, A61K38/2292, A61K47/186, A61K9/0048